Sartor G - Search Results

1

Short-term mortality in childhood onset insulin-dependent diabetes mellitus: a high frequency of unexpected deaths in bed.

Sartor G, Dahlquist G. Sartor G, et al. Diabet Med. 1995 Jul;12(7):607-11. doi: 10.1111/j.1464-5491.1995.tb00550.x. Diabet Med. 1995. PMID: 7554783

2

Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.

Sartor G, Katzman P, Eizyk E, Kalén J, Nilsson A, Ugander L, Ursing D. Sartor G, et al. Int J Clin Pharmacol Ther. 1995 Jan;33(1):3-6. Int J Clin Pharmacol Ther. 1995. PMID: 7711988 Clinical Trial.

3

The Swedish Childhood Diabetes Study: a seven-fold decrease in short-term mortality?

Sartor G, Nyström L, Dahlquist G. Sartor G, et al. Diabet Med. 1991 Jan;8(1):18-21. doi: 10.1111/j.1464-5491.1991.tb01510.x. Diabet Med. 1991. PMID: 1826238

4

Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients.

Hermann LS, Kalén J, Katzman P, Lager I, Nilsson A, Norrhamn O, Sartor G, Ugander L. Hermann LS, et al. Among authors: sartor g. Diabetes Obes Metab. 2001 Dec;3(6):428-34. doi: 10.1046/j.1463-1326.2001.00160.x. Diabetes Obes Metab. 2001. PMID: 11903415 Clinical Trial.

5

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

Knowler WC, Sartor G, Melander A, Scherstén B. Knowler WC, et al. Among authors: sartor g. Diabetologia. 1997 Jun;40(6):680-6. doi: 10.1007/s001250050734. Diabetologia. 1997. PMID: 9222648 Clinical Trial.

6

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

Sartor G, Scherstén B, Carlström S, Melander A, Nordén A, Persson G. Sartor G, et al. Diabetes. 1980 Jan;29(1):41-9. doi: 10.2337/diab.29.1.41. Diabetes. 1980. PMID: 7380107 Clinical Trial.

7

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

Sartor G, Melander A, Scherstén B, Wåhlin-Boll E. Sartor G, et al. Diabetologia. 1980 Jan;18(1):17-22. doi: 10.1007/BF01228296. Diabetologia. 1980. PMID: 6767639

8

Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.

Sartor G, Ursing D, Nilsson-Ehle P, Wåhlin-Boll E, Melander A. Sartor G, et al. Eur J Clin Pharmacol. 1987;33(3):279-82. doi: 10.1007/BF00637562. Eur J Clin Pharmacol. 1987. PMID: 3319648 Clinical Trial.

9

Long-term treatment of subjects with borderline glucose tolerance.

Carlstrom S, Persson G, Sartor G, Schersten B. Carlstrom S, et al. Among authors: sartor g. Adv Exp Med Biol. 1979;119:411-8. doi: 10.1007/978-1-4615-9110-8_60. Adv Exp Med Biol. 1979. PMID: 115234

10

Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM?

Melander A, Bitzén PO, Sartor G, Scherstén B, Wåhlin-Boll E. Melander A, et al. Among authors: sartor g. Diabetes Care. 1990 Aug;13 Suppl 3:53-8. doi: 10.2337/diacare.13.3.53. Diabetes Care. 1990. PMID: 2209345 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results